Work

Baseline characteristics of a phase III randomized controlled trial of acupuncture for chemotherapy-induced peripheral neuropathy (ACT trial).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e24173

Authors: Ting Bao, Eunbin Kwag, Raymond E. Baser, Natalie Viyaran, Anna Tanasijevic, Lauren Piluson, Qing Susan Li, Yuan Chen, Iris Zhi, Jun J. Mao

Institutions: Dana-Farber Cancer Institute, City Of Hope National Medical Center, City of Hope, Memorial Sloan Kettering Cancer Center, NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W7162689990

Cites:

Cited by:

Related to: